SEARCH

SEARCH BY CITATION

References

  • 1
    Seaberg EC, Belle SH, Beringer K, Schlaak JF, Schivins JL, Detre KM. Liver transplantation in the United States from 1987–1998: Updated results from the Pitt-UNOS Liver Transplant Registry. In: CeckaJM, TerasakiPI (eds). Clinical Transplants 1998 (ed 1). Los Angeles: UCLA Tissue Typing Laboratory; 1999: 1737.
  • 2
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815820.MEDLINE
  • 3
    Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20(suppl):S24S27.
  • 4
    Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:11371143.MEDLINE
  • 5
    O'Reilly PM, Rosen HR, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Causes of graft loss following liver transplantation for chronic hepatitis C. Transplant Proc 1997; 29:526528.MEDLINE
  • 6
    Detre KM, Belle SH, Lombardero M. Liver transplantation for chronic viral hepatitis. Viral Hepatitis Rev 1996; 2:219228.
  • 7
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28:823830.MEDLINE
  • 8
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999; 29:250256.MEDLINE
  • 9
    Gayowski T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, et al. Hepatitis C virus genotypes in liver transplant recipients: Impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997; 64:422426.MEDLINE
  • 10
    Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia. Hepatology 1996; 24:10411046.MEDLINE
  • 11
    Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:14631466.MEDLINE
  • 12
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671675.MEDLINE
  • 13
    Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998; 4:2227.MEDLINE
  • 14
    Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992; 89:13611365.MEDLINE
  • 15
    Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62:17731776.MEDLINE
  • 16
    Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998; 65:11781182.MEDLINE
  • 17
    Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203210.MEDLINE
  • 18
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:14851492.MEDLINE
  • 19
    Heathcote J, Shiffman ML, Cooksley GW, Dusheiko G, Lee SS, Balart L, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 2000; 343:16731679.MEDLINE
  • 20
    Van Thiel DH, Faruki H, Friedlander L, Fagiuoli S, Caraceni P, Molloy PJ, et al. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF. Hepatogastroenterology 1995; 42:907912.MEDLINE
  • 21
    Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [letter]. Hepatology 1994; 19:13211324.MEDLINE
  • 22
    Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:773779.MEDLINE
  • 23
    Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau JY, et al. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28:831838.MEDLINE
  • 24
    Mazzaferro V, Regalia E, Pulvirenti A, Tagger A, Andreola S, Pasquali M, et al. Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination. Transplant Proc 1997; 29:519521.MEDLINE
  • 25
    Shakil AO, McGuire B, Crippin JS, Conjeevaram HS, Teperman L, Gish R, et al. Interferon-alfa 2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C [abstract]. Hepatology 2000; 32:217A.
  • 26
    Kapur A, Rodriguez MJ, Schecter P, Tzakis A, Schiff ER. Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection [abstract]. Gastroenterology 1998; 114:1268A.
  • 27
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26:500504.MEDLINE
  • 28
    Lavezzo B, Rizzetto M, Smedile A, Ottobrelli A, Ghisetti V, Franchello A, et al. Combination therapy of interferon alfa 2b and ribavirin for recurrent hepatitis C after liver transplantation [abstract]. J Hepatol 1999; 30:67.
  • 29
    El-Amin OA, Poterucha J, Zein N, Wiesner RH, Kim WR, Charlton MR. Interferon and ribavirin therapy for recurrent hepatitis C after liver transplantation [abstract]. Hepatology 1999; 30:247A.
  • 30
    Heathcote J, Shiffman ML, Cooksley GW, Dusheiko G, Lee SS, Balart L, et al. Multinational evaluation of the efficacy and safety of once-weekly peginterferon alfa 2A (PEG-IFN) in patients with chronic hepatitis C (CHC) with compensated cirrhosis [abstract]. Hepatology 1999; 30:316A.
  • 31
    Zeuzem S, Feinman SV, Rasenack J, Heathcote J, Lai MY, Gane EJ, et al. Evaluation of the safety and efficacy of once weekly PEG/interferon alfa-2A (Pegasys) for chronic hepatitis C. A multinational, randomized study [abstract]. J Hepatol 2000; 32:29.
  • 32
    Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986; 315:15751578.MEDLINE
  • 33
    Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993; 104:11161121.MEDLINE